World's Largest TB Drug Maker Lupin Acquires German Generic Company Hormosan To Extend Reach Into Europe
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Lupin, the world's largest manufacturer of anti-TB drugs, has acquired German generics firm Hormosan Pharma GmbH to establish a "bridgehead" and sharpen its focus in the European market
You may also be interested in...
India’s Lupin Says Ready To Present Mandideep Plan To U.S. FDA; Push On Novel Drug Delivery, Biosimilars And Indian Market To Propel Revenue Growth
MUMBAI - Indian drug maker Lupin hopes to clear up issues with U.S. regulators on its Mandideep-based manufacturing unit, which has been issued warning letters by the U.S. FDA. The FDA had charged the facility deviated from current good manufacturing practices in the production of oral and injectable cephalosporins in November 2008
India’s Lupin Says Ready To Present Mandideep Plan To U.S. FDA; Push On Novel Drug Delivery, Biosimilars And Indian Market To Propel Revenue Growth
MUMBAI - Indian drug maker Lupin hopes to clear up issues with U.S. regulators on its Mandideep-based manufacturing unit, which has been issued warning letters by the U.S. FDA. The FDA had charged the facility deviated from current good manufacturing practices in the production of oral and injectable cephalosporins in November 2008
GSK Takes Lupin To Court To Block Generic Combivir Launch in the U.S.
MUMBAI - Europe's largest drugmaker GlaxoSmithKline has sued Indian drug maker Lupin for infringement of its patents for anti-AIDS drug Combivir in the U.S